Mkhikian et al. have shed light on the possibility of a unifying molecular mechanism in MS, whereby multiple genetic variants, including CTLA-4, could combine with multiple environmental factors, such as sunlight/vitamin D3 and metabolism, and could converge to dysregulate Golgi N-glycosylation [119]. Here, CTLA4 is linked to myeloid sarcoma.